Drug intelligence / Profile preview

F-5

Development stage
Unknown
Lead developer
P.B. Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

F-5 is a hematinic combination product manufactured by P&B Pharmaceuticals, primarily marketed in West African regions such as Nigeria. It is formulated as an oral tablet containing ferrous fumarate (200 mg) as a source of elemental iron, combined with a specific complex of B-vitamins: thiamine (B1), riboflavin (B2), pyridoxine (B6), cyanocobalamin (B12), and folic acid (B9). The product is indicated for the prevention and treatment of iron-deficiency anemia and associated nutritional vitamin deficiencies. It is commonly used to support increased nutritional demands during pregnancy, lactation, and convalescence. By providing both the iron necessary for hemoglobin synthesis and the essential vitamins required for effective erythropoiesis and cellular metabolism, F-5 helps restore healthy red blood cell levels and overall nutritional status.

Brand names
F-5F5F 5
Other names
F-5 TabletsF5 TabletsF 5 Tablets
02

Targets

MTR (Methionine synthase)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on F-5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on F-5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call